Date | Name | Shares | Transaction | Value |
Mar 11, 2025
| Todd W. Seyfert President & CEO |
63,758
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 11, 2025
| Todd W. Seyfert President & CEO |
23,758
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2025
| Kevin B. Reid VP & General Counsel |
24,170
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
953,748.20
|
Mar 6, 2025
| Kevin B. Reid VP & General Counsel |
20,744
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
818,558.24
|
Mar 6, 2025
| Kevin B. Reid VP & General Counsel |
12,028
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 6, 2025
| Michael W. Wilson VP of New Product Development |
15,276
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2025
| Kevin B. Reid VP & General Counsel |
19,631
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2025
| Thomas A. Dineen Treasurer and CFO |
31,507
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2025
| Thomas A. Dineen Treasurer and CFO |
19,469
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 6, 2025
| Thomas A. Dineen Treasurer and CFO |
27,480
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
1,084,360.80
|
Mar 6, 2025
| Thomas A. Dineen Treasurer and CFO |
33,454
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
1,320,094.84
|
Mar 6, 2025
| Michael W. Wilson VP of New Product Development |
1,629
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
64,280.34
|
Mar 6, 2025
| Shawn C. Leska Vice President, Sales |
8,018
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
316,390.28
|
Mar 6, 2025
| Christopher John Killoy Director |
68,247
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
Mar 6, 2025
| Christopher John Killoy Director |
42,113
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 6, 2025
| Christopher John Killoy Director |
50,861
| Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
2,006,975.06
|
Mar 6, 2025
| Christopher John Killoy Director |
63,160
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
2,492,293.60
|
Mar 6, 2025
| Michael W. Wilson VP of New Product Development |
9,360
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 6, 2025
| Shawn C. Leska Vice President, Sales |
9,485
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|
Mar 6, 2025
| Shawn C. Leska Vice President, Sales |
10,831
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $39.46 per share |
427,391.26
|